Page 43 - ARNM-2-3

Advances in Radiotherapy
& Nuclear Medicine Molecular imaging of lung cancer

doi: 10.1097/MD.0000000000033726 85. Coolen J, De Keyzer F, Nafteux P, et al. Malignant pleural
disease: Diagnosis by using diffusion-weighted and
74. Kakhki VRD. Positron emission tomography in the
management of lung cancer. Ann Thorac Med. 2007;2(2):69-76. dynamic contrast-enhanced MR imaging-initial experience.
Radiology. 2012;263(3):884-892.
doi: 10.4103/1817-1737.32235
doi: 10.1148/radiol.12110872
75. Griffeth LK. Use of PETCT scanning in cancer patients
technical and practical considerations. Proc (Bayl Univ Med 86. Hu N, Yin S, Li Q, et al. Evaluating heterogeneity of primary
Cent). 2005;18:321-330. lung tumor using clinical routine magnetic resonance
imaging and a tumor heterogeneity index. Front Oncol.
doi: 10.1080/08998280.2005.11928089 2021;10:591485.
76. Hatabu H, Ohno Y, Gefter WB, et al. Expanding applications doi: 10.3389/fonc.2020.591485
of pulmonary MRI in the clinical evaluation of lung
disorders: Fleischner Society position paper. Radiology. 87. Olson JD, Walb MC, Moore JE, et al. A gated-7T MRI
2020;297(2):286-301. technique for tracking lung tumor development and
progression in mice after exposure to low doses of ionizing
doi: 10.1148/radiol.2020201138 radiation. Radiat Res. 2012;178(4):321-327.
77. Rampinelli C, De Marco P, Origgi D, et al. Exposure to low doi: 10.1667/rr2800.1
dose computed tomography for lung cancer screening and
risk of cancer: Secondary analysis of trial data and risk- 88. Meier-Schroers M, Homsi R, Gieseke J, Schild HH,
benefit analysis. BMJ. 2017;356:j347. Thomas D. Lung cancer screening with MRI: Evaluation
of MRI for lung cancer screening by comparison of LDCT-
doi: 10.1136/bmj.j347 and MRI-derived Lung-RADS categories in the first two
78. Shah DJ, Sachs RK, Wilson DJ. Radiation-induced cancer: screening rounds. Eur Radiol. 2019;29:898-905.
A modern view. Br J Radiol. 2012;85(1020):e1166-e1173. doi: 10.1007/s00330-018-5607-8
doi: 10.1259/bjr/25026140 89. Ohno Y, Koyama H, Yoshikawa T, Matsumoto S, Sugimura K.
79. Aziz M, Krishnam M, Madhuranthakam AJ, Rajiah P. Lung cancer assessment using MR imaging: An update.
Update on MR imaging of the pulmonary vasculature. Int J Magn Reson Imaging Clin N Am. 2015;23(2):231-244.
Cardiovasc Imaging. 2019;35:1483-1497. doi: 10.1016/j.mric.2015.01.012
doi: 10.1007/s10554-019-01603-y 90. Robson MD, Gatehouse PD, Bydder M, Bydder GM.
80. Krupnick AS, Tidwell VK, Engelbach JA, et al. Quantitative Magnetic resonance: An introduction to ultrashort TE (UTE)
monitoring of murine lung tumors by magnetic resonance imaging. J Comput Assist Tomogr. 2003;27(6):825-846.
imaging. Nat Protoc. 2012;7(1):128-42. doi: 10.1097/00004728-200311000-00001
doi: 10.1038/nprot.2011.424 91. Balasch A. Functional lung magnetic resonance imaging
81. Wild JM, Marshall H, Bock M, et al. MRI of the lung (1/3): with ultra-short echo-time (UTE). 2022.Ýoi: http://dx.doi.
Methods. Insights Imaging. 2012;3:345-353. org/10.18725/OPARU-42430
doi: 10.1007/s13244-012-0176-x 92. Ma Y, Jang H, Jerban S, et al. Making the invisible visible-
ultrashort echo time magnetic resonance imaging:
82. Uto T, Takehara Y, Nakamura Y, et al. Higher sensitivity and Technical developments and applications. Appl Phys Rev.
specificity for diffusion-weighted imaging of malignant lung 2022;9(4):041303.
lesions without apparent diffusion coefficient quantification.
Radiology. 2009;252(1):247-254. doi: 10.1063/5.0086459
doi: 10.1148/radiol.2521081195 93. Johnson KM, Fain SB, Schiebler ML, Nagle S. Optimized
3D ultrashort echo time pulmonary MRI. Magn Reson Med.
83. Qi LP, Zhang XP, Tang L, Li J, Sun YS, Zhu GY. Using 2013;70(5):1241-1250.
diffusion-weighted MR imaging for tumor detection
in the collapsed lung: A preliminary study. Eur Radiol. doi: 10.1002/mrm.24570
2009;19:333-341. 94. Bergin CJ, Pauly JM, Macovski A. Lung parenchyma:
doi: 10.1007/s00330-008-1134-3 Projection reconstruction MR imaging. Radiology.
1991;179(3):777-781.
84. Satoh S, Kitazume Y, Ohdama S, Kimula Y, Taura S,
Endo Y. Can malignant and benign pulmonary nodules doi: 10.1148/radiology.179.3.2027991
be differentiated with diffusion-weighted MRI? Am J 95. Geiger J, Zeimpekis KG, Jung A, Mœller A, Kellenberger CJ.
Roentgenol. 2008;191(2):464-470.
Clinical application of ultrashort echo-time MRI for lung
doi: 10.2214/AJR.07.3133 pathologies in children. Clin Radiol. 2021;76(9):708. e9-e17.

Volume 2 Issue 3 (2024) 11 doi: 10.36922/arnm.4173